Search results
Intellia (NTLA) Shares Fall as CFO Glenn Goddard Steps Down
Zacks via Yahoo News· 1 week agoShares of Intellia Therapeutics, Inc. NTLA were down 4.5% on Jun 26 after it announced that its...
Cadence Design and Ligand have been highlighted as Zacks Bull and Bear of the Day
Zacks via Yahoo News· 11 months agoFor Immediate Release Chicago, IL – July 21, 2023 – Zacks Equity Research shares Cadence Design...
Amgen (AMGN) Wins Patent Appeal for Blockbuster Psoriasis Drug
Zacks via Yahoo News· 1 year agoThe Appeal Court's decision upholding the patents for Amgen's (AMGN) blockbuster psoriasis drug...
Will Bristol Myers (BMY) Gain From New Drugs' Label Expansion?
Zacks via Yahoo News· 1 year agoBristol-Myers Squibb BMY has recently been enjoying a string of positive regulatory updates. The...
New U.S. cancer drug prices rise 53% in five years -report
Reuters via Yahoo News· 2 years agoThe annual price of a newly-launched cancer drug in the United States averaged $283,000 last year, a...
Should Investors Buy Bristol Myers Squibb Stock?
Zacks via Yahoo News· 2 years agoBMY's YTD performance indicates the stock has been a viable hedge against inflation because people can ill afford to cut back on health-focused spending.
Will New Drugs Help Bristol Myers (BMY) Combat Generic Pressure?
Zacks via Yahoo News· 2 years agoBiotech bigwig Bristol Myers BMY has had a decent run this year despite one of its top drugs...
Bristol Myers (BMY) Gets FDA Approval for Psoriasis Candidate
Zacks via Yahoo News· 2 years agoBristol Myers (BMY) secures an FDA nod for Sotyktu to treat adults with moderate-to-severe plaque...